nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
|
Sculier, J.P. |
|
|
18 |
6 |
p. 1037-1042 |
artikel |
2 |
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
|
Natoli, C. |
|
|
18 |
6 |
p. 1015-1020 |
artikel |
3 |
Breast cancer in elderly women: a different reality? Results from the NORA study
|
Mustacchi, G. |
|
|
18 |
6 |
p. 991-996 |
artikel |
4 |
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
|
Björkholm, M. |
|
|
18 |
6 |
p. 1085-1089 |
artikel |
5 |
Epidemiology of peritoneal mesothelioma: a review
|
Boffetta, P. |
|
|
18 |
6 |
p. 985-990 |
artikel |
6 |
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
|
Cabioglu, N. |
|
|
18 |
6 |
p. 1021-1029 |
artikel |
7 |
Flavonoids and laryngeal cancer risk in Italy
|
Garavello, W. |
|
|
18 |
6 |
p. 1104-1109 |
artikel |
8 |
Follow up of three cases after adjuvant treatment of high risk gastrointestinal stromal tumors with Imatinib
|
Armbrust, T. |
|
|
18 |
6 |
p. 1123-1125 |
artikel |
9 |
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
|
Bartlett, N.L. |
|
|
18 |
6 |
p. 1071-1079 |
artikel |
10 |
Good death in cancer care: a nationwide quantitative study
|
Miyashita, M. |
|
|
18 |
6 |
p. 1090-1097 |
artikel |
11 |
Granulocyte colony-stimulating factor-associated complications and increase in leukocyte number
|
Ferretti, G. |
|
|
18 |
6 |
p. 1118-1119 |
artikel |
12 |
Hypertension as a predictive factor of Sunitinib activity
|
Rixe, O. |
|
|
18 |
6 |
p. 1117 |
artikel |
13 |
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer
|
Taillade, L. |
|
|
18 |
6 |
p. 1043-1050 |
artikel |
14 |
in this issue
|
|
|
|
18 |
6 |
p. 967 |
artikel |
15 |
Lung cancer mortality among silicotic workers in Hong Kong—no evidence for a link
|
Yu, I.T.S. |
|
|
18 |
6 |
p. 1056-1063 |
artikel |
16 |
National integration of European standards
|
Bajetta, E. |
|
|
18 |
6 |
p. 969-970 |
artikel |
17 |
Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety †
|
van Tiel, F.H. |
|
|
18 |
6 |
p. 1080-1084 |
artikel |
18 |
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial
|
Di Leo, A. |
|
|
18 |
6 |
p. 997-1003 |
artikel |
19 |
Predicting prognosis in patients with advanced cancer
|
Stone, P.C. |
|
|
18 |
6 |
p. 971-976 |
artikel |
20 |
Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast
|
Treré, D. |
|
|
18 |
6 |
p. 1004-1014 |
artikel |
21 |
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
|
Eymard, J-C |
|
|
18 |
6 |
p. 1064-1070 |
artikel |
22 |
Re: Perabo FGE and Muller SC. New agents for treatment of advanced transitional cell carcinoma. Ann Oncol 2007; 18: 835–843.
|
Di Lorenzo, G. |
|
|
18 |
6 |
p. 1118 |
artikel |
23 |
Reply to ‘Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study’ by Gorini et al.
|
Deandrea, S. |
|
|
18 |
6 |
p. 1119-1121 |
artikel |
24 |
Suicide in multiple myeloma and acute myeloid leukaemia
|
Björkholm, M. |
|
|
18 |
6 |
p. 1122-1123 |
artikel |
25 |
Table of Contents
|
|
|
|
18 |
6 |
p. iv-v |
artikel |
26 |
The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group
|
Laurie, S.A. |
|
|
18 |
6 |
p. 1051-1055 |
artikel |
27 |
The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study
|
Steward, W.P. |
|
|
18 |
6 |
p. 1098-1103 |
artikel |
28 |
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
|
Valabrega, G. |
|
|
18 |
6 |
p. 977-984 |
artikel |
29 |
Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors
|
Dirix, L.Y. |
|
|
18 |
6 |
p. 1121-1122 |
artikel |
30 |
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands
|
de Vries, E. |
|
|
18 |
6 |
p. 1110-1116 |
artikel |
31 |
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer
|
Kim, J.G. |
|
|
18 |
6 |
p. 1030-1036 |
artikel |